Rapid TB Diagnostics Network to speed better tests for TB patients
Official title: Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)
Funded at University of California, San Francisco · NIH-11607819 · Data updated 2026-11-12
A national network will identify and connect promising TB diagnostic technologies with clinical sites to speed evaluation and ensure tests work well in real-world settings, especially where TB is most common.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 11, 2025 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $501,224 |
| NIH project number | 3R01AI190419-02S4 |
| Project ID | NIH-11607819 on NIH RePORTER |
Who could benefit from this research
✓Could help
People experiencing symptoms of TB or suspected TB, especially in high-burden countries, who could benefit from better diagnostic options.
✕Less likely to help
Patients in settings where current diagnostics already meet needs or where access remains severely limited may see limited benefit.
What this research studies
This grant supports building a hub that screens new TB diagnostic tools and links developers with experienced clinical sites to test performance. It emphasizes selecting tests that meet WHO target profiles for different use cases and arranging evaluation in real-world settings. The project aims to close the diagnostic gap so more people with TB are correctly diagnosed and receive effective treatment.
Why it matters
Potential benefit: If successful, patients could get faster, more accurate TB diagnoses and timely treatment.
How similar studies have gone: Past efforts show that linking developers with clinical sites can accelerate evaluation and adoption of new TB diagnostics.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Nahid, Payam — University of California, San Francisco
- Study coordinator: Nahid, Payam
Related research
Other NIH-funded projects on the same topics.
-
How cancer cells use exosomes to evade the immune system
This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat
-
Reducing harm from smoking using electronic cigarettes
This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Cutaneous opioid signals in skin inflammation
A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.
-
Pooling international data to understand long-term bisphosphonate use and atypical femur fractures
This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.
-
Airway cell and immune cell talks in lung transplant failure
This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.